{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:49:17Z","timestamp":1758980957727},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2006,2,2]],"date-time":"2006-02-02T00:00:00Z","timestamp":1138838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1007\/s00262-005-0108-4","type":"journal-article","created":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T15:15:10Z","timestamp":1138806910000},"page":"1247-1257","source":"Crossref","is-referenced-by-count":26,"title":["The immunologically active site of prothymosin \u03b1 is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients"],"prefix":"10.1007","volume":"55","author":[{"given":"Margarita","family":"Skopeliti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis F.","family":"Voutsas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Persefoni","family":"Klimentzou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinos L.","family":"Tsiatas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristotelis","family":"Bamias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Moraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia","family":"Livaniou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Neagu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Voelter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ourania E.","family":"Tsitsilonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,2,2]]},"reference":[{"key":"108_CR1","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1073\/pnas.81.4.1008","volume":"81","author":"AA Haritos","year":"1984","unstructured":"Haritos AA, Goodall GJ, Horecker BL (1984) Prothymosin \u03b1: isolation and properties of the major immunoreactive form of thymosin \u03b11 in rat thymus. Proc Natl Acad Sci USA 81:1008\u20131011","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR2","first-page":"123","volume":"14","author":"AA Haritos","year":"1987","unstructured":"Haritos AA (1987) \u03b1-Thymosins: relationships in structure, distribution, and function. Isozymes Curr Top Biol Med Res 14:123\u2013152","journal-title":"Isozymes Curr Top Biol Med Res"},{"key":"108_CR3","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.83.24.9403","volume":"83","author":"WH Eschenfeldt","year":"1986","unstructured":"Eschenfeldt WH, Berger SL (1986) The human prothymosin \u03b1 gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc Natl Acad Sci USA 83:9403\u20139407","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0196-9781(00)00288-6","volume":"21","author":"A Pineiro","year":"2000","unstructured":"Pineiro A, Cordero OJ, Nogueira M (2000) Fifteen years of prothymosin alpha: contradictory past and new horizons. Peptides 21:1433\u20131446","journal-title":"Peptides"},{"key":"108_CR5","doi-asserted-by":"crossref","first-page":"9504","DOI":"10.1073\/pnas.90.20.9504","volume":"90","author":"OE Tsitsiloni","year":"1993","unstructured":"Tsitsiloni OE, Stiakakis J, Koutselinis A, Gogas J, Markopoulos C, Yialouris P, Bekris S, Panoussopoulos D, Kiortsis V, Voelter W, Haritos AA (1993) Expression of \u03b1-thymosins in human tissues in normal and abnormal growth. Proc Natl Acad Sci USA 90:9504\u20139507","journal-title":"Proc Natl Acad Sci USA"},{"key":"108_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/j.1460-2075.1991.tb07929.x","volume":"10","author":"M Eilers","year":"1991","unstructured":"Eilers M, Schirm S, Bishop JM (1991) The MYC protein activates transcription of the \u03b1-prothymosin gene. EMBO J 10:133\u2013141","journal-title":"EMBO J"},{"key":"108_CR7","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1074\/jbc.272.16.10506","volume":"272","author":"A Perez-Estevez","year":"1997","unstructured":"Perez-Estevez A, Diaz-Jullien C, Covelo G, Salgueiro MT, Freire M (1997) A 180-kDa protein kinase seems to be responsible for the phosphorylation of prothymosin \u03b1 observed in proliferating cells. J Biol Chem 272:10506\u201310513","journal-title":"J Biol Chem"},{"key":"108_CR8","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1016\/S0021-9258(19)67881-6","volume":"266","author":"RE Manrow","year":"1991","unstructured":"Manrow RE, Sburlati AR, Hanover JA, Berger SL (1991) Nuclear targeting of prothymosin \u03b1. J Biol Chem 266:3916\u20133924","journal-title":"J Biol Chem"},{"key":"108_CR9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0167-4838(96)00072-6","volume":"1296","author":"C Diaz-Jullien","year":"1996","unstructured":"Diaz-Jullien C, Perez-Estevez A, Covelo G, Freire M (1996) Prothymosin \u03b1 binds histones in vitro and shows activity in nucleosome assembly assay. Biochim Biophys Acta 1296:219\u2013227","journal-title":"Biochim Biophys Acta"},{"key":"108_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/embo-reports\/kvf071","volume":"3","author":"Z Karetsou","year":"2002","unstructured":"Karetsou Z, Kretsovali A, Murphy C, Tsolas O, Papamarcaki T (2002) Prothymosin \u03b1 interacts with the CREB-binding protein and potentiates transcription. EMBO Rep 3:361\u2013366","journal-title":"EMBO Rep"},{"key":"108_CR11","doi-asserted-by":"crossref","first-page":"26394","DOI":"10.1074\/jbc.272.42.26394","volume":"272","author":"MW Trumbore","year":"1997","unstructured":"Trumbore MW, Wang RH, Enkemann SA, Berger SL (1997) Prothymosin \u03b1 in vivo contains phosphorylated glutamic acid residues. J Biol Chem 272:26394\u201326404","journal-title":"J Biol Chem"},{"key":"108_CR12","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1128\/MCB.20.15.5722-5735.2000","volume":"20","author":"MA Cotter","year":"2000","unstructured":"Cotter MA, Robertson ES (2000) Modulation of histone acetyltransferase activity through interaction of Epstein-Barr nuclear antigen 3C with prothymosin alpha. Mol Cell Biol 20:5722\u20135735","journal-title":"Mol Cell Biol"},{"key":"108_CR13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.1076807","volume":"299","author":"X Jiang","year":"2003","unstructured":"Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, Donnelly J, Burns D, Ng SC, Rosenberg S, Wang X (2003) Distinctive roles of PHAP proteins and prothymosin-\u03b1 in a death regulatory pathway. Science 299:223\u2013226","journal-title":"Science"},{"key":"108_CR14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S1357-2725(99)00094-1","volume":"31","author":"F Segade","year":"1999","unstructured":"Segade F, Gomez-Marquez J (1999) Prothymosin \u03b1. Int J Biochem Cell Biol 31:1243\u20131248","journal-title":"Int J Biochem Cell Biol"},{"key":"108_CR15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/08923979009019679","volume":"12","author":"CN Baxevanis","year":"1990","unstructured":"Baxevanis CN, Frillingos S, Seferiadis K, Reclos GJ, Arsenis P, Katsiyiannis A, Anastasopoulos E, Tsolas O, Papamichail M (1990) Enhancement of human T lymphocyte function by prothymosin \u03b1: increased production of interleukin-2 and expression of interleukin-2 receptors in normal human peripheral blood T lymphocytes. Immunopharmacol Immunotoxicol 12:595\u2013617","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"108_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0192-0561(97)00024-6","volume":"19","author":"F Garbin","year":"1997","unstructured":"Garbin F, Eckert K, Immenschuh P, Kreuser ED, Maurer HR (1997) Prothymosin \u03b11 effects, in vitro, on the antitumor activity and cytokine production of blood monocytes from colorectal tumor patients. Int J Immunopharmacol 19:323\u2013332","journal-title":"Int J Immunopharmacol"},{"key":"108_CR17","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.148.7.1979","volume":"148","author":"CN Baxevanis","year":"1992","unstructured":"Baxevanis CN, \u03a4hanos D, Reclos GJ, Anastasopoulos E, Tsokos GC, Papamatheakis J, Papamichail M (1992) Prothymosin \u03b1 enhances human and murine MHC class II surface antigen expression and messenger RNA accumulation. J Immunol 148:1979\u20131984","journal-title":"J Immunol"},{"key":"108_CR18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s002620000132","volume":"49","author":"Voutsas","year":"2000","unstructured":"Voutsas IF, Baxevanis CN, Gritzapis AD, Missitzis I, Stathopoulos GP, Archodakis G, Banis C, Voelter W, Papamichail M (2000) Synergy between interleukin-2 and prothymosin \u03b1 for the increased generation of cytotoxic T lymphocytes against autologous human carcinomas. Cancer Immunol Immunother 49:449\u2013458","journal-title":"Cancer Immunol Immunother"},{"key":"108_CR19","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/BF01525392","volume":"40","author":"CN Baxevanis","year":"1995","unstructured":"Baxevanis CN, Gritzapis AD, Spanakos G, Tsitsilonis OE, Papamichail M (1995) Induction of tumor-specific T lymphocyte responses in vivo by prothymosin \u03b1. Cancer Immunol Immunother 40:410\u2013418","journal-title":"Cancer Immunol Immunother"},{"key":"108_CR20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0192-0561(97)00089-1","volume":"19","author":"H Heidecke","year":"1997","unstructured":"Heidecke H, Eckert K, Schulze-Forster K (1997) Prothymosin \u03b11 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients. Int J Immunopharmacol 19:413\u2013420","journal-title":"Int J Immunopharmacol"},{"key":"108_CR21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/(SICI)1097-4652(200002)182:2<256::AID-JCP15>3.0.CO;2-N","volume":"182","author":"SA Enkemann","year":"2000","unstructured":"Enkemann SA, Wang RH, Trumbore MW, Berger SL (2000) Functional discontinuities in prothymosin \u03b1 caused by caspase cleavage in apoptotic cells. J Cell Physiol 182:256\u2013268","journal-title":"J Cell Physiol"},{"key":"108_CR22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0014-5793(00)01139-X","volume":"467","author":"AG Evstafieva","year":"2000","unstructured":"Evstafieva AG, Belov GA, Kalkum M, Chichkova NV, Bogdanov AA, Agol VI, Vartapetian AB (2000) Prothymosin \u03b1 fragmentation in apoptosis. FEBS Lett 467:150\u2013154","journal-title":"FEBS Lett"},{"key":"108_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002620050550","volume":"48","author":"CN Baxevanis","year":"1999","unstructured":"Baxevanis CN, Spanakos G, Voutsas IF, Gritzapis AD, Tsitsilonis OE, Mamalaki A, Papamichail M (1999) Increased generation of autologous tumor-reactive lymphocytes by anti-CD3 monoclonal antibody and prothymosin \u03b1. Cancer Immunol Immunother 48:71\u201384","journal-title":"Cancer Immunol Immunother"},{"key":"108_CR24","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.4049\/jimmunol.164.7.3902","volume":"164","author":"CN Baxevanis","year":"2000","unstructured":"Baxevanis CN, Voutsas JF, Tsitsilonis OE, Gritzapis AD, Sotiriadou R, Papamichail M (2000) Tumor-specific CD4+ T lymphocytes from cancer patients are required for optimal induction of cytotoxic T cells against the autologous tumor. J Immunol 164:3902\u20133912","journal-title":"J Immunol"},{"key":"108_CR25","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1002\/1097-0142(19941115)74:10<2843::AID-CNCR2820741017>3.0.CO;2-O","volume":"74","author":"S Raziuddin","year":"1994","unstructured":"Raziuddin S, Abu-Eshy S, Sheikka A (1994) Peripheral T-cell lymphomas. Immunoregulatory cytokine (interleukin-2, interleukin-4, and interferon-\u03b3) abnormalities and autologous mixed lymphocyte reaction. Cancer 74:2843\u20132849","journal-title":"Cancer"},{"key":"108_CR26","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14712598.4.4.559","volume":"4","author":"AL Goldstein","year":"2004","unstructured":"Goldstein AL, Badamchian M (2004) Thymosins: chemistry and biological properties in health and disease. Expert Opin Biol Ther 4:559\u2013573","journal-title":"Expert Opin Biol Ther"},{"key":"108_CR27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0162-3109(95)00057-Z","volume":"29","author":"OJ Cordero","year":"1995","unstructured":"Cordero OJ, Sarandeses C, Lopez-Rodriguez JL, Nogueira M (1995) The presence and cytotoxicity of CD16+ CD2- subset from PBL and NK cells in long-term IL-2 cultures enhanced by prothymosin-\u03b1. Immunopharmacology 29:215\u2013223","journal-title":"Immunopharmacology"},{"key":"108_CR28","first-page":"420","volume":"123","author":"K Eckert","year":"1997","unstructured":"Eckert K, Gruenberg E, Immenschuh P, Gabrin F, Kreuser ED, Maurer HR (1997) Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin \u03b11. J Cancer Res Clin Oncol 123:420\u2013428","journal-title":"J Cancer Res Clin Oncol"},{"key":"108_CR29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0192-0561(94)90081-7","volume":"16","author":"K Eckert","year":"1994","unstructured":"Eckert K, Schmitt M, Gabrin F, Wahn U, Maurer HR (1994) Thymosin \u03b11 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results. Int J Immunopharmacol 16:1019\u20131025","journal-title":"Int J Immunopharmacol"},{"key":"108_CR30","first-page":"2405","volume":"14","author":"F Garbin","year":"1994","unstructured":"Garbin F, Eckert K, Buttner P, Garbe C, Maurer HR (1994) Prothymosin \u03b1 augments deficient antitumor activity of monocytes from melanoma patients in vitro. Anticancer Res 14:2405\u20132411","journal-title":"Anticancer Res"},{"key":"108_CR31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/35095564","volume":"1","author":"A Cerwenka","year":"2001","unstructured":"Cerwenka A, Lanier LL (2001) Natural killer cells, viruses and cancer. Nat Rev Immunol 1:41\u201349","journal-title":"Nat Rev Immunol"},{"key":"108_CR32","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0162-3109(88)90054-9","volume":"15","author":"CN Baxevanis","year":"1988","unstructured":"Baxevanis CN, Reclos GJ, Panneerselvam C, Papamichail M (1988) Enhancement of human T lymphocyte functions by prothymosin \u03b1. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced proliferative responses. Immunopharmacology 15:73\u201384","journal-title":"Immunopharmacology"},{"key":"108_CR33","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/ijc.2910530216","volume":"53","author":"CN Baxevanis","year":"1993","unstructured":"Baxevanis CN, Reclos GJ, Papamichail M (1993) Prothymosin \u03b1 restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer. Int J Cancer 53:264\u2013268","journal-title":"Int J Cancer"},{"key":"108_CR34","doi-asserted-by":"crossref","first-page":"7546","DOI":"10.1016\/S0021-9258(18)83269-0","volume":"264","author":"WH Eschenfeldt","year":"1989","unstructured":"Eschenfeldt WH, Manrow RE, Krug MS, Berger SL (1989) Isolation and partial sequencing of the human prothymosin \u03b1 gene family. Evidence against export of the gene products. J Biol Chem 264:7546\u20137555","journal-title":"J Biol Chem"},{"key":"108_CR35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-4827(02)00047-2","volume":"284","author":"AG Evstafieva","year":"2003","unstructured":"Evstafieva AG, Belov GA, Rubtsov YP, Kalkum M, Joseph B, Chichkova NV, Sukhacheva EA, Bogdanov AA, Pettersson RF, Agol VI, Vartapetian AB (2003) Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha. Exp Cell Res 284:211\u2013223","journal-title":"Exp Cell Res"},{"key":"108_CR36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-5793(94)80233-5","volume":"341","author":"OJ Cordero","year":"1994","unstructured":"Cordero OJ, Sarandeses C, Nogueira M (1994) Prothymosin \u03b1 receptors on peripheral blood mononuclear cells. FEBS Lett 341:23\u201327","journal-title":"FEBS Lett"},{"key":"108_CR37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0192-0561(91)90156-2","volume":"13","author":"OJ Cordero","year":"1991","unstructured":"Cordero OJ, Sarandeses CS, Lopez JL, Cancio E, Regueiro BJ, Nogueira M (1991) Prothymosin \u03b1 enhances interleukin 2 receptor expression in normal human T-lymphocytes. Int J Immunopharmacol 13:1059\u20131065","journal-title":"Int J Immunopharmacol"},{"key":"108_CR38","first-page":"175","volume":"13","author":"JL Lopez-Rodriguez","year":"1994","unstructured":"Lopez-Rodriguez JL, Cordero OJ, Sarandeses CS, Vinuela J, Nogueira M (1994) Interleukin-2 killer cells: in vitro evaluation of combination with prothymosin \u03b1. Lymphokine Cytokine Res 13:175\u2013182","journal-title":"Lymphokine Cytokine Res"},{"key":"108_CR39","first-page":"149","volume":"49","author":"WL Crump","year":"1989","unstructured":"Crump WL, Owen-Schaub LB, Grimm EA (1989) Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells. Cancer Res 49:149\u2013153","journal-title":"Cancer Res"},{"key":"108_CR40","first-page":"415","volume":"5","author":"E Gruenberg","year":"1997","unstructured":"Gruenberg E, Eckert K, Maurer R (1997) Prothymosin \u03b11 enhances the interleukin-2 activated killer cell adhesion to and immunotoxicity against docetaxel-treated HT-29 colon carcinoma cells in vitro. Int J Thymol 5:415\u2013423","journal-title":"Int J Thymol"},{"key":"108_CR41","first-page":"279","volume":"12","author":"HF Pross","year":"1993","unstructured":"Pross HF, Lotzova E (1993) Role of natural killer cells in cancer. Nat Immun 12:279\u2013292","journal-title":"Nat Immun"},{"key":"108_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-2797(03)00069-3","volume":"146","author":"SO Odman-Ghazi","year":"2003","unstructured":"Odman-Ghazi SO, Hatcher F, Whalen MM (2003) Expression of functionally relevant cell surface markers in dibutyltin-exposed human natural killer cells. Chem Biol Interact 146:1\u201318","journal-title":"Chem Biol Interact"},{"key":"108_CR43","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/blood.V95.2.602","volume":"95","author":"DM Rose","year":"2000","unstructured":"Rose DM, Cardarelli PM, Cobb RR, Ginsberg MH (2000) Soluble VCAM-1 binding to \u03b14 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells. Blood 95:602\u2013609","journal-title":"Blood"},{"key":"108_CR44","doi-asserted-by":"crossref","first-page":"13286","DOI":"10.1074\/jbc.M213005200","volume":"278","author":"CS Sarandeses","year":"2003","unstructured":"Sarandeses CS, Covello G, Diaz-Jullien C, Freire M (2003) Prothymosin \u03b1 is processed to thymosin \u03b11 and thymosin \u03b111 by a lysosomal asparaginyl endopeptidase. J Biol Chem 278:13286\u201313293","journal-title":"J Biol Chem"},{"key":"108_CR45","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/sj.gt.3301568","volume":"8","author":"AL Shiau","year":"2001","unstructured":"Shiau AL, Lin PR, Chang MY, Wu CL (2001) Retrovirus-mediated transfer of prothymosin gene inhibits tumor growth and prolongs survival in murine bladder cancer. Gene Ther 8:1609\u20131617","journal-title":"Gene Ther"},{"key":"108_CR46","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1006\/bbrc.2000.3183","volume":"274","author":"VR Shakulov","year":"2000","unstructured":"Shakulov VR, Vorobjev IA, Rubtsov YP, Chichkova NV, Vartapetian AB (2000) Interaction of yeast importin \u03b1 with the NLS of prothymosin \u03b1 is insufficient to trigger nuclear uptake of cargos. Biochem Biophys Res Commun 274:548\u2013552","journal-title":"Biochem Biophys Res Commun"},{"key":"108_CR47","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood-2003-11-4036","volume":"103","author":"L Romani","year":"2004","unstructured":"Romani L, Bistoni F, Gaziano R, Bozza S, Montagnoli C, Perruccio K, Pitzurra L, Bellocchio S, Velardi A, Rasi G, Di Francesco P, Garaci E (2004) Thymosin \u03b11 activates dendritic cells for antifungal Th1 resistance through toll-like receptor signaling. Blood 103:4232\u20134239","journal-title":"Blood"},{"key":"108_CR48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","volume":"296","author":"Matzinger","year":"2002","unstructured":"Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301\u2013305","journal-title":"Science"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0108-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-005-0108-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0108-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:42:03Z","timestamp":1683369723000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-005-0108-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2,2]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0108-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2,2]]}}}